In May 2024, Knight entered into an agreement with Ironshore Pharmaceuticals & Development, Inc., a wholly owned subsidiary of Ironshore Therapeutics, Inc. (now part of Collegium Pharmaceutical, Inc.; ...
Products are chosen independently by our editors. Purchases made through our links may earn us a commission. When I was first tested for Attention-Deficit ...
This article will focus on pharmacological treatments available for treating ADHD and the epidemiological data on their use across the life spectrum. In the UK, there are two central nervous ...
He says it is a huge impost and he worries about families who cannot afford treatment for their children. GPs are advocating for a pilot program that will allow for ADHD diagnosis and treatment ...